Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

The global motion stimulation therapy market is set for significant growth, with market projections estimating its value at USD 1.4 billion in 2024. Fueled by rapid technological integration in ...

It provides enhanced therapy personalization for symptom control that automatically adjusts, minimizing the need for patients to manually adjust stimulation. "Medtronic is the only ... Our Mission — ...

Now Medtronic has enhanced its Percept™ DBS neurostimulators ... Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across ...

There is no cure for debilitating neurological conditions like Parkinson's, however, deep brain stimulation (DBS ... Our Mission - to alleviate pain, restore health, and extend life - unites ...

Legalcategory· September 19, 2024 Axonics defeats Medtronic lawsuit in spine-stimulation patent trial Medical device maker Axonics has convinced a jury in California federal court that it did not ...

After a twitching pinky finger led to a diagnosis of young-onset Parkinson's disease, Keith Krehbiel, then 42, stopped at a ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

The company's new CEO joined the team last year from Medtronic, one of the largest medical device companies in the world.

Boston Scientific BSX is experiencing a temporary cooling-off period after its strong run in 2024, where the stock climbed 54.5%, banking on robust financial performance and product advancements ...